188 related articles for article (PubMed ID: 8097414)
1. Acid pump blockers: what are their current therapeutic roles?
Arens MJ; Dent J
Baillieres Clin Gastroenterol; 1993 Mar; 7(1):95-128. PubMed ID: 8097414
[No Abstract] [Full Text] [Related]
2. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
[No Abstract] [Full Text] [Related]
3. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Bardou M
Rev Prat; 2001 Apr; 51(7):789-95. PubMed ID: 11387678
[No Abstract] [Full Text] [Related]
4. [Lansoprazol].
Ponce J; Nos P
Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
[No Abstract] [Full Text] [Related]
5. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
6. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
7. [Indications for anti-ulcer drugs in adults].
Chassany O
Presse Med; 2000 Jan; 29(2):94-7. PubMed ID: 10682038
[No Abstract] [Full Text] [Related]
8. Rabeprazole: an update of its use in acid-related disorders.
Carswell CI; Goa KL
Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
[TBL] [Abstract][Full Text] [Related]
9. The use and abuse of histamine H2-receptor antagonists.
Milton-Thompson GJ
J R Nav Med Serv; 1977; 63(1):9-14. PubMed ID: 17005
[No Abstract] [Full Text] [Related]
10. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
Lanas Arbeloa A; Serrano Aulló MT
Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
[No Abstract] [Full Text] [Related]
11. Proton pump inhibitors.
Katelaris PH
Med J Aust; 1998 Aug; 169(4):208-11. PubMed ID: 9734580
[No Abstract] [Full Text] [Related]
12. Drug therapy of peptic ulcer disease.
Ching CK; Lam SK
Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
[TBL] [Abstract][Full Text] [Related]
13. Proton-pump inhibitors in acid-related diseases.
Berardi RR; Welage LS
Am J Health Syst Pharm; 1998 Nov; 55(21):2289-98. PubMed ID: 9825880
[No Abstract] [Full Text] [Related]
14. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
15. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
16. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
Carella G
Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411
[No Abstract] [Full Text] [Related]
17. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
Meijer JL; Jansen JB; Lamers CB
Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060
[TBL] [Abstract][Full Text] [Related]
18. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
Bown RL
Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700
[TBL] [Abstract][Full Text] [Related]
19. [Experience in the use of losek (omeprazole) in gastroenterology].
Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI
Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419
[No Abstract] [Full Text] [Related]
20. Atypical and aggressive upper gastrointestinal ulceration associated with aspirin abuse.
Hirschowitz BI; Lanas A
J Clin Gastroenterol; 2002; 34(5):523-8. PubMed ID: 11960062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
